Scinai Immunotherapeutics Ltd. - American Depositary Shares SCNI 深 滬
等待開盤 10-24 09:30:00 美东时间
1.42
+0.030
+2.16%
華盛通- 最 高1.4654
- 今 開1.36
- 成交量 5.31万股
- 最 低 1.35
- 昨 收 1.39
- 總市值 141.99万
- 52周最高 6.18
- 市盈率 靜 0.24
- 換手率 0.00%
- 52周最低 1.20
- 委 比 -5.01%
- 總股本 99.99万
- 歷史最高 6200.00
- 量 比 0.41
- 振 幅 8.30%
- 歷史最低 1.20
- 每 手 1
- 風險率 0.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
Scinai Immunotherapeutics ( ($SCNI) ) has issued an announcement. On October 6,...
10-06 20:20
Scinai Immunotherapeutic Awarded Grant Of About $246K From Israel Innovation Authority To Finance Project To Acquire, Install Fill-And-finish System For Sterile Manufacturing
Grant funds two-thirds of a NIS 1.23 million ($373K) project to strengthen Scinai Bioservices' small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies in Israel and
10-06 19:38
Scinai Immunotherapeutics reports 1H results
Scinai Immunotherapeutics press release (NASDAQ:SCNI): 1H Revenue of $0.77M. Net loss was $4,134 thousand, compared to $4,481 thousand in the six months ended June 30, 2024, reflecting higher revenues...
09-02 20:58
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Celestica Inc. (NYSE:CLS) rose sharply in pre-market trading after th...
07-29 18:46
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
07-02 20:06
Scinai Immunotherapeutics shares are trading higher after the company announced that it was granted clearance under the Golden Power regulation for Scinai's option to acquire 100% of the share capital and voting rights of Pincell.
Scinai Immunotherapeutics shares are trading higher after the company announced...
06-05 22:37
Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth
Scinai Immunotherapeutics Ltd. Sponsored Adr ( ($SCNI) ) has released its Q4 ea...
06-05 11:55
Scinai Immunotherapeutics Reports Strong CDMO Growth
Scinai Immunotherapeutics Ltd. Sponsored Adr ( ($SCNI) ) has released its Q1 ea...
06-03 11:54
Scinai Immunotherapeutics reports FY results
Scinai Immunotherapeutics press release (NASDAQ:SCNI): FY Revenue of $0.65M. Financial income, net in 2024, amounted to $13.5 million compared to $3.2 million for 2023. The increase was primarily due...
05-08 05:46
